IPS細胞衍生類器官的全球市場:類型·用途·終端用戶·不同地區的預測 (～2032年)

全球IPS細胞衍生類器官市場規模預計將從2023年的4.4億美元成長到2024年的5.1億美元，預測期內複合年增長率為17.8%，到2032年將達到18%。至9000 萬美元。

IPS 細胞衍生的類器官市場代表了生物醫學研究和藥物開發的突破。這些由誘導多能幹細胞 (iPS 細胞) 創建的微型 3D 組織模型為研究人類生理學、疾病機制和藥物療效提供了前所未有的機會。類器官有多種應用，包括疾病建模、藥物發現、個人化醫療和再生治療。在技​​術進步、個人化醫療需求不斷增長以及藥物發現和再生醫學應用不斷擴大的推動下，iPS 細胞衍生的類器官市場預計將顯著增長。然而，克服技術、監管和道德挑戰對於充分發揮這項創新技術的潛力至關重要。

區域洞察

北美 IPS 細胞衍生類器官市場擁有強大的研究基礎設施、對生命科學的大量投資以及蓬勃發展的生物技術產業。該地區擁有乾細胞研究前沿的一些頂尖大學和研究中心，該市場正在接受大量公共和私人投資，以推動 iPS 細胞衍生類器官的開發和應用。北美擁有完善的醫療體系，很容易引進先進的醫療技術。先進的研究設施和熟練的專業人員的存在也進一步促進了市場的成長。該地區的技術採用工作正在加速基於類器官的平台的開發和應用。支持性的監管框架也鼓勵對類器官研究和發展的投資。

由於其對醫療保健的關注和推動市場發展的強大科學界，歐洲在 IPS 細胞衍生類器官市場中佔有第二大佔有率。德國 IPS 細胞衍生類器官供應商預計將佔據最大的市場佔有率，而法國 IPS 細胞衍生類器官供應商預計將成為該地區成長最快的。

由於生物醫學研究投資的增加、醫療保健支出的增加以及慢性病患病率的上升推動了IPS 細胞衍生類器官的研究和開發，預計亞太地區IPS 細胞衍生類器官市場將在2023 年實現增長。

本報告提供全球IPS細胞衍生類器官的市場調查，市場定義和概要，市場成長的各種影響因素分析，市場規模的轉變·預測，各種區分·地區/各主要國家的明細，競爭環境，主要企業簡介等資訊。

目錄

第1章 摘要整理

第2章 市場概要

第3章 調查手法

第4章 市場動態

• 促進因素
  • 越來越多採用個人化藥物
  • 慢性病的蔓延
  • 幹細胞研究的進展
  • 促進因素影響分析
• 阻礙因素
  • 開發維護類器官的成本高昂
  • 監管障礙和標準化
  • 抑制因子影響分析
• 機會
  • 開發更複雜、功能更豐富的類器官
  • 擴大在藥物發現和毒理學的應用
• COVID-19影響分析

第5章 市場要素分析

• 波特的五力分析
• 供應鏈分析

第6章 全球IPS細胞衍生類器官市場:各類型

• 概要
• 腦
• 心臟
• 肺
• 肝臟
• 腎臟
• 其他

第7章 全球IPS細胞衍生類器官市場:各用途

• 概要
• 醫藥品的發現·開發
• 疾病建模
• 再生醫療

第8章 全球IPS細胞衍生類器官市場:各終端用戶

• 概要
• 製藥·生物科技企業
• 學術研究機關
• CRO

第9章 全球IPS細胞衍生類器官市場:各地區

• 概要
• 北美
• 歐洲
• 亞太地區
• 其他地區

第10章 競爭情形

• 主要成長策略
• 競爭儀表板

第11章 企業簡介

• ACROBIOSYSTEMS
• MILTENYI BIOTEC
• THERMOFISHER SCIENTIFIC
• STEMCELL TECHNOLOGIES
• BIO-TECHNE
• MERCK KGAA
• MOLECULAR DEVICES, LLC
• CORNING INCORPORATED
• PROMEGA CORPORATION
• CREATIVE BIOARRAY

Global IPS Cell Derived Organoids Market Research Report Information by Type (Brain Organoids, Heart Organoids, Lung Organoids, Liver Organoids, Kidney Organoids, and Others), by Application (Drug Discovery and Development, Disease Modelling, and Regenerative Medicine), by End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Contract Research Organization), and by Region (North America, Europe, Asia-Pacific, and Rest of the World Forecast till 2032

An Overview of the Market

IPS Cell Derived Organoids Market size was valued at USD 0.44 billion in 2023. The IPS Cell Derived Organoids Market industry is projected to grow from USD 0.51 billion in 2024 to USD 1.89 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 17.8% during the forecast period (2024 - 2032).

IPS cell-derived organoids market represent a revolutionary advancement in biomedical research and drug development. These miniature, three-dimensional tissue models, generated from induced pluripotent stem cells (iPSCs), offer unprecedented opportunities for studying human physiology, disease mechanisms, and drug efficacy. Organoids are used in various applications, including disease modelling, drug discovery, personalized medicine, and regenerative therapies. The iPS cell-derived organoids market is poised for substantial growth, driven by technological advancements, increasing demand for personalized medicine, and expanding applications in drug discovery and regenerative medicine. However, overcoming technical, regulatory, and ethical challenges will be crucial for realizing the full potential of this transformative technology.

Market segmentation insights

The IPS Cell Derived Organoids Market segmentation, based on type, includes Brain Organoids, Heart Organoids, Lung Organoids, Liver Organoids, Kidney Organoids, and Others.

The IPS Cell Derived Organoids Market segmentation, based on application, includes drug discovery and development, disease modelling, and regenerative medicine.

Regional Insights

The IPS Cell Derived Organoids market in America boasts a robust research infrastructure, substantial investments in life sciences, and a thriving biotechnology industry. North America is home to several top-tier universities and research centers that are at the forefront of stem cell research. This region has seen substantial investments from both public and private sectors aimed at advancing the development and application of iPS cell-derived organoids. The well-established healthcare systems in North America facilitate the adoption of advanced medical technologies. The presence of sophisticated laboratory facilities and skilled professionals further supports market growth. The region's inclination towards technological adoption has fostered the development and application of organoid-based platforms. Supportive regulatory frameworks encourage investments in organoid research and development.

Europe IPS Cell Derived Organoids market accounted for the second-largest market share due to region's emphasis on healthcare, coupled with a strong scientific community, drives the market. Furthermore, the Germany IPS Cell Derived Organoids provider attributed to hold the largest market share, and the France IPS Cell Derived Organoids providers is projected be the fastest growing market in the Europe region.

The Asia-Pacific IPS Cell Derived Organoids market is expected to be the fastest growing from 2023 to 2032 due to increasing investments in biomedical research, growing healthcare expenditure, and a rising prevalence of chronic diseases can support IPS Cell Derived Organoids development.

Prominent Participants

Key Companies in the IPS Cell Derived Organoids market includes ACROBiosystems (US), Miltenyi Biotec (Germany), ThermoFisher Scientific (US), STEMCELL Technologies (Canada), Bio-Techne (US), Merck KGaA (Germany), Molecular Devices, LLC (US), Corning Incorporated (US), Promega Corporation (US), and Creative Bioarray (US).

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

• 2.1 DEFINITION
• 2.2 SCOPE OF THE STUDY
• 2.3 RESEARCH OBJECTIVE
• 2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

• 3.1 OVERVIEW
• 3.2 DATA FLOW
  • 3.2.1 DATA MINING PROCESS
• 3.3 PURCHASED DATABASE:
• 3.4 SECONDARY SOURCES:
  • 3.4.1 SECONDARY RESEARCH DATA FLOW:
• 3.5 PRIMARY RESEARCH:
  • 3.5.1 PRIMARY RESEARCH DATA FLOW:
  • 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
  • 3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE
• 3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
  • 3.6.1 REVENUE ANALYSIS APPROACH
• 3.7 DATA FORECASTING
  • 3.7.1 DATA FORECASTING TECHNIQUE
• 3.8 DATA MODELING
  • 3.8.1 MICROECONOMIC FACTOR ANALYSIS:
  • 3.8.2 DATA MODELING:

4 MARKET DYNAMICS

• 4.1 INTRODUCTION
• 4.2 DRIVERS
  • 4.2.1 GROWING ADOPTION OF PERSONALIZED DRUGS
  • 4.2.2 RISING PREVALENCE OF CHRONIC DISEASES
  • 4.2.3 ADVANCEMENTS IN STEM CELL RESEARCH
  • 4.2.4 DRIVER IMPACT ANALYSIS
• 4.3 RESTRAINTS
  • 4.3.1 HIGH COST OF ORGANOID DEVELOPMENT AND MAINTENANCE
  • 4.3.2 REGULATORY HURDLES AND STANDARDIZATION
  • 4.3.3 RESTRAINT IMPACT ANALYSIS
• 4.4 OPPORTUNITY
  • 4.4.1 DEVELOPMENT OF MORE COMPLEX AND FUNCTIONAL ORGANOIDS
  • 4.4.2 EXPANSION OF APPLICATIONS IN DRUG DISCOVERY AND TOXICOLOGY
• 4.5 IMPACT ANALYSIS OF COVID -
  • 4.5.1 IMPACT ON OVERALL HEALTH INDUSTRY
  • 4.5.2 IMPACT ON GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET
  • 4.5.3 IMPACT ON SUPPLY CHAIN OF IPS CELL-DERIVED ORGANOIDS
  • 4.5.4 IMPACT ON MARKET DEMAND OF IPS CELL-DERIVED ORGANOIDS
  • 4.5.5 IMPACT ON PRICING OF IPS CELL-DERIVED ORGANOIDS

5 MARKET FACTOR ANALYSIS

• 5.1 PORTER'S FIVE FORCES MODEL
  • 5.1.1 THREAT OF NEW ENTRANTS
  • 5.1.2 BARGAINING POWER OF SUPPLIERS
  • 5.1.3 BARGAINING POWER OF BUYERS
  • 5.1.4 THREAT OF SUBSTITUTES
  • 5.1.5 INTENSITY OF RIVALRY
• 5.2 SUPPLY CHAIN ANALYSIS
  • 5.2.1 RAW MATERIAL
  • 5.2.2 PRODUCTION PROCESS
  • 5.2.3 DISTRIBUTION
  • 5.2.4 END USER

6 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE

• 6.1 OVERVIEW
• 6.2 BRAIN
• 6.3 HEART
• 6.4 LUNG
• 6.5 LIVER
• 6.6 KIDNEY
• 6.7 OTHERS

7 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION

• 7.1 OVERVIEW
• 7.2 DRUG DISCOVERY AND DEVELOPMENT
• 7.3 DISEASE MODELLING
• 7.4 REGENERATIVE MEDICINE

8 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER

• 8.1 OVERVIEW
• 8.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
• 8.3 ACADEMIC AND RESEARCH INSTITUTES
• 8.4 CONTRACT RESEARCH ORGANIZATION

9 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET, BY REGION

• 9.1 OVERVIEW
  • 9.1.1 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET, BY REGION, 2020-2032
• 9.2 NORTH AMERICA
  • 9.2.1 NORTH AMERICA: IPS CELL-DERIVED ORGANOIDS MARKET, BY COUNTRY, 2020-2032
• 9.3 EUROPE
  • 9.3.1 EUROPE: IPS CELL-DERIVED ORGANOIDS MARKET, BY COUNTRY, 2020-2032
• 9.4 ASIA PACIFIC
  • 9.4.1 ASIA PACIFIC: IPS CELL-DERIVED ORGANOIDS MARKET, BY COUNTRY, 2020-2032
• 9.5 REST OF THE WORLD
  • 9.5.1 REST OF THE WORLD: IPS CELL-DERIVED ORGANOIDS MARKET, BY COUNTRY, 2020-2032

10 COMPETITIVE LANDSCAPE

• 10.1 INTRODUCTION
• 10.2 MAJOR GROWTH STRATEGY IN THE GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET
• 10.3 COMPETITOR DASHBOARD

11 COMPANY PROFILES

• 11.1 ACROBIOSYSTEMS
  • 11.1.1 COMPANY OVERVIEW
  • 11.1.2 FINANCIAL OVERVIEW
  • 11.1.3 PRODUCTS OFFERED
  • 11.1.4 KEY DEVELOPMENTS
  • 11.1.5 SWOT ANALYSIS
  • 11.1.6 KEY STRATEGIES
• 11.2 MILTENYI BIOTEC
  • 11.2.1 COMPANY OVERVIEW
  • 11.2.2 FINANCIAL OVERVIEW
  • 11.2.3 PRODUCTS OFFERED
  • 11.2.4 KEY DEVELOPMENTS
  • 11.2.5 SWOT ANALYSIS
  • 11.2.6 KEY STRATEGIES
• 11.3 THERMOFISHER SCIENTIFIC
  • 11.3.1 COMPANY OVERVIEW
  • 11.3.2 FINANCIAL OVERVIEW
  • 11.3.3 PRODUCTS OFFERED
  • 11.3.4 KEY DEVELOPMENTS
  • 11.3.5 SWOT ANALYSIS
  • 11.3.6 KEY STRATEGIES
• 11.4 STEMCELL TECHNOLOGIES
  • 11.4.1 COMPANY OVERVIEW
  • 11.4.2 FINANCIAL OVERVIEW
  • 11.4.3 PRODUCTS OFFERED
  • 11.4.4 KEY DEVELOPMENTS
  • 11.4.5 SWOT ANALYSIS
  • 11.4.6 KEY STRATEGIES
• 11.5 BIO-TECHNE
  • 11.5.1 COMPANY OVERVIEW
  • 11.5.2 FINANCIAL OVERVIEW
  • 11.5.3 PRODUCTS OFFERED
  • 11.5.4 KEY DEVELOPMENTS
  • 11.5.5 KEY STRATEGIES
• 11.6 MERCK KGAA
  • 11.6.1 COMPANY OVERVIEW
  • 11.6.2 FINANCIAL OVERVIEW
  • 11.6.3 PRODUCTS OFFERED
  • 11.6.4 KEY DEVELOPMENTS
  • 11.6.5 SWOT ANALYSIS
  • 11.6.6 KEY STRATEGIES
• 11.7 MOLECULAR DEVICES, LLC
  • 11.7.1 COMPANY OVERVIEW
  • 11.7.2 FINANCIAL OVERVIEW
  • 11.7.3 PRODUCTS OFFERED
  • 11.7.4 KEY DEVELOPMENTS
  • 11.7.5 KEY STRATEGIES
• 11.8 CORNING INCORPORATED
  • 11.8.1 COMPANY OVERVIEW
  • 11.8.2 FINANCIAL OVERVIEW
  • 11.8.3 PRODUCTS OFFERED
  • 11.8.4 KEY DEVELOPMENTS
  • 11.8.5 KEY STRATEGIES
• 11.9 PROMEGA CORPORATION
  • 11.9.1 COMPANY OVERVIEW
  • 11.9.2 FINANCIAL OVERVIEW
  • 11.9.3 PRODUCTS OFFERED
  • 11.9.4 KEY DEVELOPMENTS
  • 11.9.5 KEY STRATEGIES
• 11.10 CREATIVE BIOARRAY
  • 11.10.1 COMPANY OVERVIEW
  • 11.10.2 FINANCIAL OVERVIEW
  • 11.10.3 PRODUCTS OFFERED
  • 11.10.4 KEY DEVELOPMENTS
  • 11.10.5 KEY STRATEGIES

LIST OF TABLES

• TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
• TABLE 2 GLOBAL: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 3 GLOBAL: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 4 GLOBAL: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 5 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET, BY REGION, 2019-2032 (USD MILLION)
• TABLE 6 NORTH AMERICA: IPS CELL-DERIVED ORGANOIDS MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
• TABLE 7 NORTH AMERICA: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 8 NORTH AMERICA: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 9 NORTH AMERICA: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 10 USA: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 11 USA: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 12 USA: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 13 CANADA: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 14 CANADA: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 15 CANADA: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 16 EUROPE: IPS CELL-DERIVED ORGANOIDS MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
• TABLE 17 EUROPE: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 18 EUROPE: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 19 EUROPE: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 20 GERMANY: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 21 GERMANY: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 22 GERMANY: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 23 UK: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 24 UK: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 25 UK: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 26 FRANCE: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 27 FRANCE: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 28 FRANCE: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 29 ITALY: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 30 ITALY: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 31 ITALY: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 32 SPAIN: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 33 SPAIN: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 34 SPAIN: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 35 REST OF EUROPE: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 36 REST OF EUROPE: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 37 REST OF EUROPE: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 38 ASIA PACIFIC: IPS CELL-DERIVED ORGANOIDS MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
• TABLE 39 ASIA PACIFIC: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 40 ASIA PACIFIC: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 41 ASIA PACIFIC: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 42 CHINA: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 43 CHINA: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 44 CHINA: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 45 INDIA: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 46 INDIA: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 47 INDIA: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 48 JAPAN: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 49 JAPAN: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 50 JAPAN: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 51 SOUTH KOREA: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 52 SOUTH KOREA: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 53 SOUTH KOREA: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 54 AUSTRALIA: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 55 AUSTRALIA: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 56 AUSTRALIA: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 57 REST OF APAC: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 58 REST OF APAC: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 59 REST OF APAC: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 60 REST OF THE WORLD: IPS CELL-DERIVED ORGANOIDS MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
• TABLE 61 REST OF WORLD: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 62 REST OF WORLD: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 63 REST OF WORLD: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 64 MIDDLE EAST & AFRICA: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 65 MIDDLE EAST & AFRICA: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 66 MIDDLE EAST & AFRICA: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 67 SOUTH AMERICA: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 68 SOUTH AMERICA: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 69 SOUTH AMERICA: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 70 ACROBIOSYSTEMS: PRODUCTS OFFERED
• TABLE 71 ACROBIOSYSTEMS: KEY DEVELOPMENTS
• TABLE 72 MILTENYI BIOTEC: PRODUCTS OFFERED
• TABLE 73 THERMO FISHER SCIENTIFIC INC: PRODUCTS OFFERED
• TABLE 74 STEMCELL TECHNOLOGIES: PRODUCTS OFFERED
• TABLE 75 BIO-TECHNE CORP: PRODUCTS OFFERED
• TABLE 76 MERCK KGAA: PRODUCTS OFFERED
• TABLE 77 MOLECULAR DEVICES.: PRODUCTS OFFERED
• TABLE 78 CORNING INCORPORATED: PRODUCTS OFFERED
• TABLE 79 PROMEGA CORPORATION.: PRODUCTS OFFERED
• TABLE 80 CREATIVE BIOARRAY: PRODUCTS OFFERED

LIST OF FIGURES

• FIGURE 1 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET: STRUCTURE
• FIGURE 2 MARKET DYNAMICS: GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET
• FIGURE 3 DRIVER IMPACT ANALYSIS: GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET
• FIGURE 4 RESTRAINT IMPACT ANALYSIS: GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET
• FIGURE 5 PORTER'S FIVE FORCES ANALYSIS: GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET
• FIGURE 6 SUPPLY CHAIN ANALYSIS: GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET
• FIGURE 7 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2023 (% SHARE)
• FIGURE 8 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• FIGURE 9 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2023 (% SHARE)
• FIGURE 10 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET, BY PRICING, 2019-2032 (USD MILLION)
• FIGURE 11 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2023 (% SHARE)
• FIGURE 12 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET, BY AGE CATEGORY, 2019-2032 (USD MILLION)
• FIGURE 13 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET, BY REGION, 2023 (% SHARE)
• FIGURE 14 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET, BY REGION, 2019-2032 (USD MILLION)
• FIGURE 15 NORTH AMERICA: IPS CELL-DERIVED ORGANOIDS MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
• FIGURE 16 EUROPE: IPS CELL-DERIVED ORGANOIDS MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
• FIGURE 17 ASIA PACIFIC: IPS CELL-DERIVED ORGANOIDS MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
• FIGURE 18 MIDDLE EAST & AFRICA: IPS CELL-DERIVED ORGANOIDS MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
• FIGURE 19 COMPETITOR DASHBOARD: GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET
• FIGURE 20 ACROBIOSYSTEMS: SWOT ANALYSIS
• FIGURE 21 MILTENYI BIOTEC: SWOT ANALYSIS
• FIGURE 22 THERMO FISHER SCIENTIFIC INC: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 23 THERMO FISHER SCIENTIFIC INC: SWOT ANALYSIS
• FIGURE 24 STEMCELL TECHNOLOGIES: SWOT ANALYSIS
• FIGURE 25 MERCK KGAA: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 26 MERCK KGAA: SWOT ANALYSIS
• FIGURE 27 CORNING INCORPORATED: FINANCIAL OVERVIEW SNAPSHOT